Vol 7 n° 1 - Early stages of schizophrenia
Past issues Contributors How to publish Contributions and comments Home
 
C o n t e n t s
3
Editorial
Jean-Paul Macher, Marc-Antoine Crocq
In this issue
Michael Davidson
State of the art
The treatment of schizophrenia: from premorbid manifestations
to the first episode of psychosis  
Michael Davidson, Asaf Caspi, Shlomo Noy
Basic research
Early biomarkers of psychosis
Robert Freedman, Randal Ross, Sherry Leonard,
Marina Myles-Worsley, Catherine E. Adams, Merilyne Waldo,
Jason Tregellas, Laura Martin, Ann Olincy, Jody Tanabe,
Michael A. Kisley, Sharon Hunter, Karen E. Stevens
Cognitive impairment as a risk factor for psychosis
Abraham Reichenberg
Pharmacological aspects
Treating early psychosis: who, what, and when?
Barbara A. Cornblatt, Andrea M. Auther
Poster
Functional neuroimaging in first-episode psychosis
Mihai D. Gheorghe, A. V. Baloescu, Gabriella Grigorescu, A. Petrescu
Clinical research
Toward a world consensus on prevention of schizophrenia
Jim Van Os, Philippe Delespaul
Environmental risk factors for psychosis
Kimberlie Dean, Robin M. Murray
Interpreting the association between cannabis use and
increased risk for schizophrenia
Mark Weiser, Shlomo Noy
ISSUE COORDINATED BY:
Carol A. TAMMINGA and Michael DAVIDSON